Passage Bio Inc (PASG)
1.36
+0.02
(+1.49%)
USD |
NASDAQ |
May 17, 16:00
1.36
0.00 (0.00%)
After-Hours: 20:00
Passage Bio Enterprise Value: -23.16M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | -23.16M |
| May 16, 2024 | -21.93M |
| May 15, 2024 | -25.62M |
| May 14, 2024 | -22.85M |
| May 13, 2024 | -13.30M |
| May 10, 2024 | -13.91M |
| May 09, 2024 | -14.53M |
| May 08, 2024 | -12.06M |
| May 07, 2024 | -7.133M |
| May 06, 2024 | -17.65M |
| May 03, 2024 | -23.81M |
| May 02, 2024 | -21.97M |
| May 01, 2024 | -21.35M |
| April 30, 2024 | -25.05M |
| April 29, 2024 | -24.43M |
| April 26, 2024 | -23.20M |
| April 25, 2024 | -29.36M |
| April 24, 2024 | -28.13M |
| April 23, 2024 | -28.74M |
| April 22, 2024 | -34.29M |
| April 19, 2024 | -33.67M |
| April 18, 2024 | -30.59M |
| April 17, 2024 | -26.28M |
| April 16, 2024 | -28.13M |
| April 15, 2024 | -28.74M |
| Date | Value |
|---|---|
| April 12, 2024 | -21.97M |
| April 11, 2024 | -20.73M |
| April 10, 2024 | -26.89M |
| April 09, 2024 | -23.20M |
| April 08, 2024 | -21.35M |
| April 05, 2024 | -16.42M |
| April 04, 2024 | -21.04M |
| April 03, 2024 | -21.35M |
| April 02, 2024 | -24.43M |
| April 01, 2024 | -20.12M |
| March 28, 2024 | -31.12M |
| March 27, 2024 | -41.44M |
| March 26, 2024 | -43.67M |
| March 25, 2024 | -39.22M |
| March 22, 2024 | -36.99M |
| March 21, 2024 | -38.11M |
| March 20, 2024 | -29.21M |
| March 19, 2024 | -36.44M |
| March 18, 2024 | -33.10M |
| March 15, 2024 | -30.90M |
| March 14, 2024 | -44.80M |
| March 13, 2024 | -43.68M |
| March 12, 2024 | -39.79M |
| March 11, 2024 | -36.46M |
| March 08, 2024 | -33.68M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-178.57M
Minimum
May 11 2022
1.269B
Maximum
Jun 23 2020
140.43M
Average
-39.22M
Median
Mar 25 2024
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 5.156M |
| Palatin Technologies Inc | 22.26M |
| iBio Inc | 16.77M |
| Theriva Biologics Inc | -8.901M |
| Oragenics Inc | 8.862M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.71M |
| Total Expenses (Quarterly) | 18.05M |
| EPS Diluted (Quarterly) | -0.30 |
| Earnings Yield | -115.9% |